MAPT and colorectal cancer: The peak in 2022 may reflect three factors: post-COVID-19 research recovery, increased surgeries for elderly colorectal cancer, and anesthesia neurotoxicity controversies (such as the explosion of research on the effects of sevoflurane on tau protein).